NDC 72934-1013

BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 4%

Benzoyl Peroxide 2.5% / Clindamycin 1% / Niacinamide 4%

BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 4% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Benzoyl Peroxide; Niacinamide; Clindamycin Phosphate.

Product ID72934-1013_8738c9c8-17ca-b7b7-e053-2a91aa0acdfb
NDC72934-1013
Product TypeHuman Prescription Drug
Proprietary NameBENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 4%
Generic NameBenzoyl Peroxide 2.5% / Clindamycin 1% / Niacinamide 4%
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date2019-05-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameBENZOYL PEROXIDE; NIACINAMIDE; CLINDAMYCIN PHOSPHATE
Active Ingredient Strength3 g/100g; g/100g; g/100g
Pharm ClassesDecreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-1013-2

30 g in 1 BOTTLE, PUMP (72934-1013-2)
Marketing Start Date2019-05-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-1013-2 [72934101302]

BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 4% GEL
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2019-05-01

Drug Details

Active Ingredients

IngredientStrength
BENZOYL PEROXIDE2.5 g/100g

Pharmacological Class

  • Decreased Sebaceous Gland Activity [PE]
  • Lincosamide Antibacterial [EPC]
  • Lincosamides [CS]
  • Decreased Sebaceous Gland Activity [PE]
  • Lincosamide Antibacterial [EPC]
  • Lincosamides [CS]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.